Bilde av Haugnes, Hege Sagstuen
Bilde av Haugnes, Hege Sagstuen
Department of Clinical Medicine hege.sagstuen.haugnes@uit.no +47 99277080

Hege Sagstuen Haugnes


Professor in oncology

Job description

I work 50% as full professor at UiT, combined with 50% as consultant and head of uro-oncology at University Hospital North Norway 


  • Martin Støyten, Tore Knutsen, Einar Stikbakke, Ingvild Agledahl, Tom Wilsgaard, Anne Elise Eggen et al.:
    Excess weight, weight gain, and prostate cancer risk and prognosis: the PROCA-life study
    Acta Oncologica 2024 ARKIV / DOI
  • Axel Gerdtsson, Helene Francisca Stigter Negaard, Bjarte Almås, Anna Grenabo Bergdahl, Gabriella Cohn-Cedermark, Ingrid Glimelius et al.:
    Initial surveillance in men with marker negative clinical stage IIA non-seminomatous germ cell tumours
    BJU International 2024 ARKIV / DOI
  • Anna Thor, Helene Francisca Stigter Negaard, Anna Grenabo Bergdahl, Bjarte Almås, Signe Melsen Larsen, Per-Olof Lundgren et al.:
    Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience
    European Urology Open Science 2024 ARKIV / DOI
  • Sven Löffeler, Helena Maria Bertilsson, Christoph Rainer Müller, Kirsti Aas, Hege Sagstuen Haugnes, Bjørg Yksnøy Aksnessæther et al.:
    Protocol of a randomised, controlled trial comparing immediate curative therapy with conservative treatment in men aged ≥75 years with non-metastatic high-risk prostate cancer (SPCG 19/GRand-P)
    BJU International 2024 ARKIV / DOI
  • Anna Thor, Mette Pernille Myklebust, Anna Grenabo Bergdahl, Per-Olof Lundgren, Viktor Skokic, Bjarte Almås et al.:
    miR-371a-3p Predicting Viable Tumor in Patients Undergoing Retroperitoneal Lymph Node Dissection for Metastatic Testicular Cancer: The SWENOTECA-MIR Study
    Journal of Urology 2024 DOI
  • Rune Sundset, Hege Sagstuen Haugnes, Alexander Perez, Ola Engelsen, Ida Fosseide, Miguel Castillejo et al.:
    Behandling av kastrasjonsresistent metastatisk prostatakreft med [177Lu]PSMA-radioligand
    Tidsskrift for Den norske legeforening 2024 DOI
  • Sophie Dorothea Fosså, Hege Sagstuen Haugnes, Alv A Dahl, Cecilie E. Kiserud, Alexander Fosså, Jakob Rasmussen Skalleberg et al.:
    Adverse health outcomes and global quality of life in long-term testicular cancer survivors: a longitudinal 30-year perspective
    Annals of Oncology 21. September 2023 DOI
  • Axel Gerdtsson, Gustav Torisson, Anna Thor, Anna Grenabo Bergdahl, Bjarte Almås, Ulf Håkansson et al.:
    Validation of a prediction model for post-chemotherapy fibrosis in nonseminoma patients
    BJU International 2023 ARKIV / DOI
  • Line Veronika Hjelle, Marie Grøn Sælen, Erling Johan Aarsæther, Tore Knutsen, Sigve Andersen, Anne Gry Bentzen et al.:
    The Longitudinal Course of Prospectively Recorded Patient-reported Outcomes in Prostate Cancer Patients Treated with Surgery and Salvage Radiotherapy
    European Urology Open Science 2023 ARKIV / DOI
  • Lene Thorsen, Kerry S. Courneya, Jostein Steene-Johannessen, Jon Michael Gran, Hege Sagstuen Haugnes, Helene Francisca Stigter Negaard et al.:
    Association of physical activity with overall mortality among long-term testicular cancer survivors: A longitudinal study
    International Journal of Cancer 2023 ARKIV / DOI
  • Ramesh Upreti, Elia Mmbaga, Hege Sagstuen Haugnes, Cecilie E. Kiserud, Ruby del Risco Kollerud :
    Most common health problems in general practice among adolescents, and young adults’ survivors of lymphoma: a register-based cohort study in Norway
    Acta Oncologica 2023 ARKIV / DOI
  • Marie Grøn Sælen, Line Veronika Hjelle, Erling Johan Aarsæther, Tore Knutsen, Sigve Andersen, Anne Gry Bentzen et al.:
    Patient-reported outcomes after curative treatment for prostate cancer with prostatectomy, primary radiotherapy or salvage radiotherapy
    Acta Oncologica 2023 ARKIV / DOI
  • Sophie Dorothea Fosså, Alv A Dahl, Lene Thorsen, Ragnhild Hellesnes, Cecilie E. Kiserud, Torgrim Tandstad et al.:
    Mortality and Second Cancer Incidence after Treatment for Testicular Cancer: Psychosocial Health and Lifestyle Are Modifiable Prognostic Factors
    Journal of Clinical Oncology 05. April 2022 ARKIV / DOI
  • Einar Stikbakke, Tom Wilsgaard, Hege Sagstuen Haugnes, Mona Irene Pedersen, Tore Knutsen, Martin Støyten et al.:
    Expression of miR-24-1-5p in Tumor Tissue Influences Prostate Cancer Recurrence: The PROCA-life Study
    Cancers 2022 ARKIV / DOI
  • Jan Oldenburg, D.M. Berney, C. Bokemeyer, Miguel Angel Climent, G. Daugaard, Jourik A. Gietema et al.:
    Testicular seminoma and non-seminoma: ESMO-EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up
    Annals of Oncology 2022 DOI
  • Ragnhild Hellesnes, Tor Åge Myklebust, Roy M. Bremnes, Åsa Karlsdottir, Øivind Kvammen, Helene Francisca Stigter Negaard et al.:
    Metachronous Contralateral Testicular Cancer in the Cisplatin Era: A Population-Based Cohort Study
    Journal of Clinical Oncology 2021 FULLTEKST / ARKIV / DOI
  • Hege S. Haugnes, Helene Francisca Stigter Negaard, Hilde Jensvoll, Tom Wilsgaard, Torgrim Tandstad, Arne Solberg :
    Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000–2014: A Population-based Cohort Study
    European Urology Open Science 15. August 2021 ARKIV / DOI
  • Einar Stikbakke, Henrik Schirmer, Tore Knutsen, Martin Støyten, Tom Wilsgaard, Edward L. Giovannucci et al.:
    Systolic and diastolic blood pressure, prostate cancer risk, treatment, and survival. The PROCA-life study
    Cancer Medicine 2021 ARKIV / DOI
  • Ragnhild Hellesnes, Tor Åge Myklebust, Sophie Dorothea Fosså, Roy M. Bremnes, Åsa Karlsdottir, Øivind Kvammen et al.:
    Testicular cancer in the cisplatin era: Causes of death and mortality rates in a population-based cohort
    Journal of Clinical Oncology 13. August 2021 ARKIV / DOI
  • Mette Pernille Myklebust, Anna Thor, Nina Benedikte Rosenlund, Peder Gjengstø, Åsa Karlsdottir, Marianne Brydøy et al.:
    Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study
    Scientific Reports 2021 ARKIV / DOI
  • Axel Gerdtsson, Anna Thor, Anna Bergdahl Grenabo, Bjarte Almås, Ulf Håkansson, Magnus Törnblom et al.:
    Unilateral or Bilateral Retroperitoneal Lymph Node Dissection in Nonseminoma Patients with Postchemotherapy Residual Tumour? Results from RETROP, a Population-based Mapping Study by the Swedish Norwegian Testicular Cancer Group
    European Urology Oncology (EUO) 06. March 2021 DOI
  • Anders W. Bjerring, Sophie Dorothea Fosså, Hege Sagstuen Haugnes, Ragnhild Veline Nome, Thomas Muri Stokke, Kristina Haugaa et al.:
    The cardiac impact of cisplatin-based chemotherapy in survivors of testicular cancer: A 30-year follow-up
    European Heart Journal-Cardiovascular Imaging 2021 ARKIV / DOI
  • Axel Gerdtsson, Ulf Håkansson, Magnus Törnblom, George Jancke, Helene Francisca Stigter Negaard, Ingrid Glimelius et al.:
    Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group
    European Urology Oncology (EUO) 2020 ARKIV / DOI
  • Sophie Dorothea Fosså, Alv A Dahl, Tor Åge Myklebust, Cecilie E. Kiserud, Ragnhild Veline Nome, Olbjørn Klepp et al.:
    Risk of positive selection bias in longitudinal surveys among cancer survivors: Lessons learnt from the national Norwegian Testicular Cancer Survivor Study
    Cancer Epidemiology 09. July 2020 DOI
  • Synne-Kristin Hoffart Bøhn, Hanne Cathrine Lie, Kristin Valborg Reinertsen, Sophie Dorothea Fosså, Hege Sagstuen Haugnes, Cecilie E. Kiserud et al.:
    Lifestyle among long-term survivors of cancers in young adulthood
    Supportive Care in Cancer 2020 ARKIV / DOI
  • Ruby Del Risco Kollerud, Hege Sagstuen Haugnes, Bjørgulf Claussen, Magne Thoresen, Per Nafstad, James Farnham et al.:
    A population-based study of testicular cancer risk among children and young adults from Norway and Utah, USA.
    International Journal of Cancer 2020 ARKIV / DOI
  • Ruby Del Risco Kollerud, LA Cannon-Albright, Hege Sagstuen Haugnes, Ellen Ruud, Magne Thoresen, Per Nafstad et al.:
    Childhood central nervous system tumors and leukemia: Incidence and familial risk. A comparative population-based study in Utah and Norway.
    Pediatric Blood & Cancer 2020 ARKIV / DOI
  • Hanne Skjerven Bersvendsen, Hege Sagstuen Haugnes, Alv A Dahl, Unn-Merete Fagerli, Øystein Fluge, Harald Holte et al.:
    Sexual dysfunction is prevalent in female lymphoma survivors after autologous stem-cell transplantation and is associated with younger age, chronic fatigue, and mental distress
    Bone Marrow Transplantation 03. November 2020 DOI
  • Lene Thorsen, Hege Sagstuen Haugnes, Sophie Dorothea Fosså, Marianne Brydøy, Torgrim Tandstad, Torbjørn Wisløff et al.:
    Thromboembolic events after high-intensity training duringcisplatin-based chemotherapy for testicular cancer: Casereports and review of the literature
    International Journal of Cancer 2020 ARKIV / DOI
  • Synne-Kristin Hoffart Bøhn, Lene Thorsen, Cecilie E. Kiserud, Sophie Dorothea Fosså, Hanne Cathrine Lie, Jon Håvard Loge et al.:
    Chronic fatigue and associated factors among long-term survivors of cancers in young adulthood
    Acta Oncologica 2019 ARKIV / DOI
  • Hanne Skjerven Bersvendsen, Hege Sagstuen Haugnes, Unn-Merete Fagerli, Øystein Fluge, Harald Holte, Knut Bjøro Smeland et al.:
    Lifestyle behavior among lymphoma survivors after high-dose therapy with autologous hematopoietic stem cell transplantation, assessed by patient-reported outcomes
    Acta Oncologica 2019 ARKIV / DOI
  • Ruby Del Risco Kollerud, Ellen Ruud, Hege Sagstuen Haugnes, Lisa A. Cannon-Albright, Magne Thoresen, Per Nafstad et al.:
    Family history of cancer and risk of paediatric and young adult’s testicular cancer: A Norwegian cohort study
    British Journal of Cancer 2019 ARKIV / FULLTEKST / DOI
  • Cecilie Bucher-Johannessen, Christian Magnus Page, Trine B. Haugen, Marcin Wojewodzic, Sophie Dorothea Fosså, Tom Grotmol et al.:
    Cisplatin treatment of testicular cancer patients introduces long-term changes in the epigenome
    Clinical Epigenetics 03. December 2019 ARKIV / DOI
  • Hanne Skjerven Bersvendsen, Hege Sagstuen Haugnes, Alv A Dahl, Unn-Merete Fagerli, Øystein Fluge, Harald Holte et al.:
    Sexual function in long-term male lymphoma survivors after high-dose therapy with autologous stem-cell transplantation
    Bone Marrow Transplantation 2019 ARKIV / DOI
  • Einar Stikbakke, Elin Richardsen, Tore Knutsen, Tom Wilsgaard, Edward L. Giovannucci, Anne McTiernan et al.:
    Inflammatory serum markers and risk and severity of prostate cancer: The PROCA‐life study
    International Journal of Cancer 2019 ARKIV / DOI
  • Yahia Al-Jebari, Ingrid Glimelius, Carina Berglund Nord, Gabriella Cohn-Cedermark, Olof Ståhl, Torgrim Tandstad et al.:
    Cancer therapy and risk of congenital malformations in children fathered by men treated for testicular germ-cell cancer: A nationwide register study
    Nature Methods 2019 ARKIV / DOI
  • Ragnhild Hellesnes, Øivind Kvammen, Tor Åge Myklebust, Roy M. Bremnes, Åsa Karlsdottir, Helene Francisca Stigter Negaard et al.:
    Continuing increased risk of second cancer in long-term testicular cancer survivors after treatment in the cisplatin era
    International Journal of Cancer 2019 FULLTEKST / ARKIV / DOI
  • Richard Cathomas, Dirk Klingbiel, Brandon Bernard, Anja Lorch, Xavier Garcia del Muro, Franco Morelli et al.:
    Questioning the value of fluorodeoxyglucose positron emission tomography for residual lesions after chemotherapy for metastatic seminoma: Results of an International Global Germ Cell Cancer Group Registry
    Journal of Clinical Oncology 2018 DOI
  • F Honecker, J Aparicio, D Berney, J Beyer, C Bokemeyer, R Cathomas et al.:
    ESMO consensus conference on testicular germ cell cancer: Diagnosis, treatment and follow-up
    Annals of Oncology 2018 DOI
  • Line Veronika Hjelle, Per Ole Mobråten Gundersen, Ragnhild Hellesnes, Mette Sprauten, Marianne Brydøy, Torgrim Tanstad et al.:
    Long-term serum platinum changes and their association with cisplatin-related late effects in testicular cancer survivors
    Acta Oncologica 2018 DOI
  • Marie K Langberg, Carina Berglund-Nord, Gabriella Cohn-Cedermark, Hege Sagstuen Haugnes, Torgrim Tandstad, Carl W. Langberg :
    Imatinib may reduce chemotherapy-induced pneumonitis. A report on four cases from the SWENOTECA
    Acta Oncologica 2018 DOI
  • Hege Sagstuen Haugnes, Niels Christian Stenklev, Marianne Brydøy, Olav Dahl, Tom Wilsgaard, Einar Laukli et al.:
    Hearing loss before and after cisplatin-based chemotherapy in testicular cancer survivors: a longitudinal study
    Acta Oncologica 2018 DOI
  • Torgrim Tandstad, Ragnhild Hellesnes, Hege Sagstuen Haugnes, Åsa Karlsdottir, Carl W. Langberg, Helene Francisca Stigter Negaard et al.:
    Late relapses in testicular cancer: Results from a national cohort
    Journal of Clinical Oncology 2022 FULLTEKST / DOI
  • Ingerid Skjei Knudtsen, Bendik Skarre Abrahamsen, Kirsten Margrete Selnæs, Mattijs Elschot, Sverre Langørgen, Thomas Keil et al.:
    PSMA-PET-avbildning før primærbehandling av pasienter med høyrisiko prostatakreft
    2022
  • Hege Sagstuen Haugnes :
    Presentasjon av seneffekt poliklinikken ved UNN
    2022
  • Torgrim Tandstad, Ragnhild Hellesnes, Åsa Karlsdottir, Øivind Kvammen, Carl W. Langberg, Helene Francisca Stigter Negaard et al.:
    Late relapse in testicular cancer: A report from a national cohort. Oral presentation
    2022
  • Hege Sagstuen Haugnes :
    Presentasjon av kreft seneffekt poliklinikken ved UNN
    2022
  • B. Jordan, A. Margulies, F. Cardoso, G. Cavaletti, Hege Sagstuen Haugnes, P. Jahn et al.:
    Systemic anticancer therapy-induced peripheral and central neurotoxicity: ESMO–EONS–EANO Clinical Practice Guidelines for diagnosis, prevention, treatment and follow-up
    Annals of Oncology 2020 DOI
  • Cecilie Bucher-Johannessen, Christian M. Page, Trine B. Haugen, Sophie Dorothea Fosså, Hege Sagstuen Haugnes, Tom Grotmol et al.:
    Epigenetic changes in testicular cancer survivors treated with cisplatin
    2018
  • Einar Stikbakke, Hege Sagstuen Haugnes, Inger Thune, Tom Wilsgaard, Anne Elise Eggen, Tore Knutsen et al.:
    Pre-diagnostic Inflammation Score and risk of Prostate Cancer. The PROCA-life study
    2018

  • The 50 latest publications is shown on this page. See all publications in Cristin here →


    Research interests

    My main research interests are related to 1) long-term effects after cancer treatment, 2) diagnostics, treatment and follow-up within urologic cancers (mainly testicular cancer and prostate cancer) and 3) clinical cancer research projects within the Tromsø study (prostate cancer and breast cancer).

    Teaching

    I have several years of experience in teaching oncology, and is currently responsible for teraching 6.4F at campus Hammerfest.